title: Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease.
authors.affiliation: Paediatric Rheumatology, AOU Meyer, Florence, Italy ilaria.pagnini@gmail.com.
authors.forename: Ilaria
authors.initials: I
authors.lastname: Pagnini
authors.affiliation: Paediatric Rheumatology, AOU Meyer, Florence, Italy.
authors.forename: Tommaso
authors.initials: T
authors.lastname: Bondi
authors.affiliation: Paediatric Rheumatology, AOU Meyer, Florence, Italy.
authors.forename: Gabriele
authors.initials: G
authors.lastname: Simonini
authors.affiliation: Paediatric Rheumatology, AOU Meyer, Florence, Italy.
authors.forename: Teresa
authors.initials: T
authors.lastname: Giani
authors.affiliation: Paediatric Rheumatology, AOU Meyer, Florence, Italy.
authors.forename: Achille
authors.initials: A
authors.lastname: Marino
authors.affiliation: Paediatric Rheumatology, AOU Meyer, Florence, Italy.
authors.forename: Rolando
authors.initials: R
authors.lastname: Cimaz
mesh_terms: D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001528:Behcet Syndrome / Q000188:drug therapy*; D002648:Child; D004351:Drug Resistance; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053583:Interleukin-1beta / Q000276:immunology; D008297:Male; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D053583:Interleukin-1beta; C541220:canakinumab